C84.7A Abrechenbarer, spezifischer Code Anaplastic large cell lymphoma, ALK-negative, breast

ICD-10-CM C84.7A identifies “Anaplastic large cell lymphoma, ALK-negative, breast” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Kapitel 2: Neoplasms

Hinweise zum Code

Inclusion terms1

Breast implant associated anaplastic large cell lymphoma (BIA-ALCL)

Use additional code3
  • code to identify:
  • breast implant status (Z98.82)
  • personal history of breast implant removal (Z98.86)

Hinweise übergeordneter Ebenen

Kapitel 2 · Neoplasms (C00-D49)

Note8
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)

Excludes 24
  • Kaposi's sarcoma of lymph nodes (C46.3)
  • secondary and unspecified neoplasm of lymph nodes (C77.-)
  • secondary neoplasm of bone marrow (C79.52)
  • secondary neoplasm of spleen (C78.89)

C84 · Mature T/NK-cell lymphomas

Excludes 11

personal history of non-Hodgkin lymphoma (Z85.72)

C84.7 · Anaplastic large cell lymphoma, ALK-negative

Excludes 11

primary cutaneous CD30-positive T-cell proliferations (C86.6-)

Verweise im offiziellen Index

Verweise im offiziellen Index (1)

Lymphoma(of) (malignant) (1)

Offizielle Konversionshistorie

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Gültigkeitszeitraum 2021-10-01

Frühere Zuordnung: C84.79

Verlauf

Codeverlauf

Letzte erfasste Änderung · FY2022

GeändertUnverändert
FY2022

Gültig ab

  • Hinzugefügt

Anaplastic large cell lymphoma, ALK-negative, breast

Abrechenbarer Diagnosecode

CDC/NCHS · FY2022

Alle Ausgaben (11)

Alle AusgabenGültig abCodeverlauf
FY20222021-10-01Hinzugefügt
FY2022 · 04-012022-04-01Keine tabellarische Änderung
FY20232022-10-01Keine tabellarische Änderung
FY2023 · 04-012023-04-01Keine tabellarische Änderung
FY20242023-10-01Keine tabellarische Änderung
FY2024 · 04-012024-04-01Keine tabellarische Änderung
FY20252024-10-01Keine tabellarische Änderung
FY2025 · 04-012025-04-01Keine tabellarische Änderung
FY20262025-10-01Keine tabellarische Änderung
FY2026 · April2026-04-01Keine tabellarische Änderung
FY20272026-10-01Keine tabellarische Änderung

Dieser Eintrag ist ein vollständiger Code in der gewählten Ausgabe. Die Referenzprüfung bestätigt keine klinische Eignung und garantiert keine Erstattung.